Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Becton, Dickinson and Co (BDX)
:BDX
BDX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$218.75 - $251.99
Previous CloseN/A
Volume443.35K
Average Volume (3M)2.14M
Market Cap
$64.64B
Enterprise Value$83.81B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)37.4
Beta0.44
Next Earnings
May 01, 2025EPS Estimate
3.3Next Dividend Ex-Date
Mar 10, 2025Dividend Yield1.73%
Share Statistics
EPS (TTM)6.02
Shares Outstanding287,135,400
10 Day Avg. Volume2,191,742
30 Day Avg. Volume2,142,913
Standard Deviation0.06
R-Squared0.14
Alpha-0.00384
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.17
Price to Cash Flow (P/CF)23.60
P/FCF Ratio27.80
Enterprise Value/Market Cap1.30
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit9.18
Enterprise Value/Ebitda22.75
Forecast
1Y Price Target
$271.10Price Target Upside18.94% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
---
Bulls Say, Bears Say
Bulls Say
Business StrategyBecton Dickinson’s ongoing positive transformation clearly took a meaningful positive step forward with the announcement of the Diagnostics business separation.
Financial PerformanceF1Q revenue of $5.17B beat the Street's $5.10B forecast, reflecting organic growth of 3.9%.
Bears Say
Cost ConcernsBDX shares were pressured due to remainCo stranded cost, stand-up cost, and dilution concerns in the absence of separation-related financial specifics.
---
Ownership Overview
0.14% Insiders
23.98% Mutual Funds
25.42% Other Institutional Investors
29.09% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Macro & PoliticalRisks related to catastrophic events or geopolitical conditions that may disrupt the company’s business
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BDX FAQ
What was Becton, Dickinson and Co’s price range in the past 12 months?
Becton, Dickinson and Co lowest stock price was $218.75 and its highest was $251.99 in the past 12 months.
What is Becton, Dickinson and Co’s market cap?
Becton, Dickinson and Co’s market cap is $64.64B.
When is Becton, Dickinson and Co’s upcoming earnings report date?
Becton, Dickinson and Co’s upcoming earnings report date is May 01, 2025 which is in 69 days.
How were Becton, Dickinson and Co’s earnings last quarter?
Becton, Dickinson and Co released its earnings results on Feb 05, 2025. The company reported $3.43 earnings per share for the quarter, beating the consensus estimate of $2.978 by $0.452.
Is Becton, Dickinson and Co overvalued?
According to Wall Street analysts Becton, Dickinson and Co’s price is currently Undervalued.
Does Becton, Dickinson and Co pay dividends?
Becton, Dickinson and Co pays a Quarterly dividend of $3.886 which represents an annual dividend yield of 1.73%. See more information on Becton, Dickinson and Co dividends here
What is Becton, Dickinson and Co’s EPS estimate?
Becton, Dickinson and Co’s EPS estimate is 3.3.
How many shares outstanding does Becton, Dickinson and Co have?
Becton, Dickinson and Co has 287,135,400 shares outstanding.
What happened to Becton, Dickinson and Co’s price movement after its last earnings report?
Becton, Dickinson and Co reported an EPS of $3.43 in its last earnings report, beating expectations of $2.978. Following the earnings report the stock price went down -7.284%.
Which hedge fund is a major shareholder of Becton, Dickinson and Co?
Currently, no hedge funds are holding shares in BDX
---
Becton Dickinson Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$271.10 (18.94% Upside)
$271.10 (18.94% Upside)
Blogger Sentiment
Bullish
BDX Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 27.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 0.6%
Last 30 Days ▲ 10.2%
Last 30 Days ▲ 10.2%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-3.68%
12-Months-Change
Fundamentals
Return on Equity
6.92%
Trailing 12-Months
Asset Growth
4.57%
Trailing 12-Months
Company Description
Becton, Dickinson and Co
Founded in 1897, Becton, Dickinson & Co. is a New Jersey-based medical technology company. The company develops, manufactures and sells medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. It operates through the following segments: BD Medical, BD Life Sciences and BD Interventional.
---
BDX Company Deck
---
BDX Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a strong Q1 performance with significant revenue growth, shareholder returns, and innovation launches. However, challenges in China, Biosciences, and translational currency impacts were noted as headwinds.Read More>---
BDX Revenue Breakdown
57.80% U.S.
21.82% EMEA
14.40% Greater Asia
5.98% Other
---
BDX Stock 12 Month Forecast
Average Price Target
$271.10
▲(18.94% Upside)
Technical Analysis
Best Analysts Covering BDX
1 Year
1 Year Success Rate
8/13 ratings generated profit
1 Year Average Return
+4.70%
reiterated a buy rating 3 months ago
Copying David Toung's trades and holding each position for 1 Year would result in 61.54% of your transactions generating a profit, with an average return of +4.70% per trade.
---